Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
17 Oct 2024 |
CS01 |
Confirmation statement made on 6 October 2024 with updates
|
|
|
17 Oct 2024 |
SH01 |
Statement of capital following an allotment of shares on 31 May 2024
|
|
|
28 Aug 2024 |
PSC02 |
Notification of Crism Therapeutics Corporation as a person with significant control on 29 May 2024
|
|
|
16 Aug 2024 |
PSC07 |
Cessation of Andrew James Webb as a person with significant control on 29 May 2024
|
|
|
05 Aug 2024 |
AD01 |
Registered office address changed from Douglas Bank House Wigan Lane Wigan Lancashire WN1 2TB United Kingdom to 6 Heddon Street London W1B 4BT on 5 August 2024
|
|
|
10 Jul 2024 |
CERTNM |
Company name changed extruded pharmaceuticals LTD\certificate issued on 10/07/24
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2024-07-03
|
|
|
04 Jun 2024 |
TM02 |
Termination of appointment of David Keith Lawton as a secretary on 31 May 2024
|
|
|
04 Jun 2024 |
TM01 |
Termination of appointment of David Keith Lawton as a director on 31 May 2024
|
|
|
04 Jun 2024 |
TM01 |
Termination of appointment of Brian Murray as a director on 31 May 2024
|
|
|
10 May 2024 |
AA |
Total exemption full accounts made up to 31 December 2023
|
|
|
30 Apr 2024 |
SH01 |
Statement of capital following an allotment of shares on 29 April 2024
|
|
|
13 Apr 2024 |
PSC07 |
Cessation of David Keith Lawton as a person with significant control on 9 February 2024
|
|
|
11 Apr 2024 |
PSC01 |
Notification of Andrew James Webb as a person with significant control on 9 February 2024
|
|
|
08 Apr 2024 |
SH01 |
Statement of capital following an allotment of shares on 9 February 2024
|
|
|
08 Apr 2024 |
SH01 |
Statement of capital following an allotment of shares on 19 March 2024
|
|
|
15 Mar 2024 |
AA01 |
Previous accounting period shortened from 31 March 2024 to 31 December 2023
|
|
|
17 Feb 2024 |
RESOLUTIONS |
Resolutions
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
17 Feb 2024 |
MA |
Memorandum and Articles of Association
|
|
|
25 Jan 2024 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES13 ‐
Subdivision of 100 ordinary shares of £1.00 each into 10000 ordinary shares of £0.01 each 18/01/2024
|
|
|
25 Jan 2024 |
RESOLUTIONS |
Resolutions
-
RES13 ‐
Sub-divsion of shares/ directors be authorise to issue up to 1,000 £0.01 ordinary shares to new investors 18/01/2024
|
|
|
25 Jan 2024 |
SH02 |
Sub-division of shares on 18 January 2024
|
|
|
17 Jan 2024 |
CH01 |
Director's details changed for Mr Andrew James Webb on 17 January 2024
|
|
|
17 Jan 2024 |
CH01 |
Director's details changed for Mr Brian Murray on 17 January 2024
|
|
|
17 Jan 2024 |
CH01 |
Director's details changed for Mr Christopher Mcconville on 17 January 2024
|
|
|
17 Jan 2024 |
CH03 |
Secretary's details changed for Mr David Keith Lawton on 17 January 2024
|
|